Is my hand numbness carpal tunnel or B12?

Carpal tunnel typically affects one hand, the thumb-side fingers, and is worse at night. B12 neuropathy is symmetric and usually involves the feet as well.

Is methylcobalamin better than cyanocobalamin?

Most neuropathy trials use methylcobalamin, but head-to-head evidence for superiority is weak. Both correct deficiency.

How long should I take it?

Indefinitely, if the cause — metformin, PPI use, veganism, malabsorption — remains in place.

Can numbness be permanent?

Yes. Once demyelination progresses to axonal loss, recovery is limited, which is why early treatment matters.

Condition

Moderate Evidence

Effectiveness 3/5

Vitamin B12 for Hand Numbness

When numbness stems from B12 deficiency — common in vegans, older adults and metformin users — supplementation reliably halts and often reverses the neuropathy if caught early. It does nothing for mechanical nerve compression like carpal tunnel, so the cause must be identified first.

Overview

Hand numbness has a long differential and B12 deficiency is only one entry on it — but it is the entry that is both easily tested and genuinely reversible. Where deficiency is the driver, 1,000 mcg daily halts the neuropathy and often reverses it, particularly when caught in the first months. The more common causes of numb hands are mechanical: carpal tunnel syndrome, cervical spine disease, ulnar compression at the elbow. None of these respond to B12, and a symmetric glove-distribution pattern rather than a single nerve territory is the clue that points towards a nutritional cause.

Pattern matters

Symmetric numbness in both hands, often with the feet involved, suggests neuropathy. Numbness in the thumb, index and middle finger of one hand suggests carpal tunnel.

Give it eight to twelve weeks for early change and up to six months for fuller recovery. Metformin users, long-term PPI users, vegans and older adults should be screened before anything else is considered.

How It Works

Vitamin B12 is required to maintain the myelin sheath that insulates peripheral nerves. Deficiency impairs methylmalonyl-CoA mutase activity, allowing abnormal odd-chain fatty acids into myelin and driving demyelination in the longest and most metabolically demanding fibres first.

Methylcobalamin is the active coenzyme form and is the form used in most neuropathy trials, on the reasoning that it directly supports the methylation reactions involved in myelin repair. Once adequate levels are restored, remyelination proceeds over weeks to months — but only where axons are intact, which is why duration of deficiency predicts recovery better than severity of the numbers.

Key mechanisms

Maintains peripheral nerve myelin

Methylcobalamin is the active coenzyme form

Longest fibres affected first

Remyelination over weeks to months

Recovery depends on axonal integrity

Dosing & Protocol

One thousand micrograms of oral B12 daily is the baseline. For established neuropathy, several trials have used higher-dose methylcobalamin around 1,500 mcg daily in divided doses, and that is a reasonable approach for the first three months where symptoms are active. Intramuscular administration is preferred where absorption is impaired by gastric surgery, autoimmune gastritis or pernicious anaemia, and where deficits are progressing quickly. Continue indefinitely if the underlying cause has not been removed.

Scenario	Dose	Form	Timing
Confirmed deficiency	1,000 mcg daily	Oral cyanocobalamin or methylcobalamin	Daily
Active neuropathy protocol	1,500 mcg daily in divided doses	Methylcobalamin	Split morning and evening, 12 weeks
Impaired absorption	1,000 mcg intramuscular	Hydroxocobalamin	Loading then maintenance, prescriber-directed
Long-term maintenance	500-1,000 mcg daily	Oral	Ongoing while the cause persists

1
Characterise the numbness· Before starting
Symmetric and bilateral, or single-nerve distribution? Night-time thumb-side tingling points to carpal tunnel, not deficiency.
2
Test B12, and MMA if borderline· Before starting
Serum B12 in the low-normal range is unreliable; methylmalonic acid and homocysteine resolve it.
3
Treat at 1,000-1,500 mcg daily· Weeks 1-12
Higher divided-dose methylcobalamin for active neuropathy over the first twelve weeks.
4
Review at three and six months· Months 3-6
Early improvement suggests remyelination. Absence of any change by three months means reconsider the diagnosis.

Do not delay

The window for reversal narrows with time. Numbness present for years is much less likely to resolve than numbness present for months.

Evidence

The linked one-year randomised, double-blind, placebo-controlled trial in diabetic neuropathy is the strongest single piece of evidence here: it tested sustained B12 supplementation against placebo with objective neurophysiological endpoints, rather than relying on symptom reports alone.

Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial

Score: 8/10

2021

rct

n=90

Didangelos T, Karlafti E, Kotzakioulafi E +5 more

The treatment of patients with DN with 1 mg of oral methylcobalamin for twelve months increased plasma B12 levels and improved all neurophysiological parameters, sudomotor function, pain score, and QoL, but it did not improve CARTS and MNSIE.

View source

Extrapolating from that trial to all hand numbness is where care is needed. The population was specifically at risk of drug-induced deficiency, and there is no evidence that B12 helps numbness in people with normal status.

Safety

B12 has no established toxicity and excess is renally cleared. Rare acneiform eruptions occur at high doses. The clinically meaningful hazards are diagnostic rather than pharmacological: masking coexisting folate deficiency, and delaying assessment of a compressive lesion that would benefit from decompression.

Progressive weakness needs assessment

Numbness accompanied by weakness, wasting or bladder symptoms requires prompt medical review rather than a supplement trial.

Interactions & Conflicts

The important interactions are the drugs that cause the deficiency.

Interacts with	Severity	Mechanism	Action
		—	—
		—	—
		—	—
		—	—
		—	—

References

Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 2021. doi:10.3390/nu13020395 (PMID 33513879)

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.